NeuroOne Medical Technologies Corporation Marketing Expense
NeuroOne Medical Technologies Corporation (NMTC) reported Marketing Expense of $227.24 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:MarketingExpense · last filed 2026-08-13
- NeuroOne Medical Technologies Corporation marketing expense for the quarter ending 2026-06-30 was $227.24K, a 11.32% increase year-over-year.
- NeuroOne Medical Technologies Corporation marketing expense for the quarter ending 2026-03-31 was $216.66K, a 7.75% increase year-over-year.
- NeuroOne Medical Technologies Corporation marketing expense for the quarter ending 2025-12-31 was $257.08K, a 39.59% increase year-over-year.
- NeuroOne Medical Technologies Corporation marketing expense for the quarter ending 2025-09-30 was $243.26K.
- NeuroOne Medical Technologies Corporation marketing expense for fiscal 2025 was $832.64K, a 6.20% increase from fiscal 2024.
- NeuroOne Medical Technologies Corporation marketing expense for fiscal 2024 was $784.02K.
| Period end | Marketing Expense 3 month | Marketing Expense 6 month | Marketing Expense 9 month | Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $227.24K 10-Q · filed 2026-08-13 | $443.90K derived: sum of 2 quarters · filed 2026-08-13 | $700.98K 10-Q · filed 2026-08-13 | $944.24K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $216.66K 10-Q/A · filed 2026-06-12 | $473.74K 10-Q/A · filed 2026-06-12 | $717.00K derived: sum of 3 quarters · filed 2026-06-12 | $921.13K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $257.08K 10-Q · filed 2026-02-17 | $500.34K derived: sum of 2 quarters · filed 2026-02-17 | $704.47K derived: sum of 3 quarters · filed 2026-08-13 | $905.55K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $243.26K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $447.39K derived: sum of 2 quarters · filed 2026-08-13 | $648.47K derived: sum of 3 quarters · filed 2026-08-13 | $832.64K 10-K · filed 2025-12-17 |
| 2025-06-30 | $204.13K 10-Q · filed 2026-08-13 | $405.22K derived: sum of 2 quarters · filed 2026-08-13 | $589.39K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $201.08K 10-Q/A · filed 2026-06-12 | $385.25K 10-Q/A · filed 2026-06-12 | ||
| 2024-12-31 | $184.17K 10-Q · filed 2026-02-17 | |||
| 2024-09-30 | $784.02K 10-K · filed 2025-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |